• Search Research Projects
  • Search Researchers
  • How to Use
  1. Back to previous page

SHIGEHIRO TSUKASA  重廣 司

ORCIDConnect your ORCID iD *help
… Alternative Names

Shigehiro Tsukasa  重廣 司

Less
Researcher Number 30876058
Other IDs
Affiliation (Current) 2025: 東京理科大学, 研究推進機構生命医科学研究所, 講師
Affiliation (based on the past Project Information) *help 2025: 東京理科大学, 研究推進機構生命医科学研究所, 講師
2020 – 2023: 東京理科大学, 研究推進機構生命医科学研究所, 助教
Review Section/Research Field
Principal Investigator
Basic Section 54010:Hematology and medical oncology-related / 0901:Oncology and related fields
Keywords
Principal Investigator
キメラ抗原受容体 / 疲弊化 / NK細胞療法 / T細胞受容体 / T細胞免疫療法 / CAR-NK細胞 / キメラ抗原受容体(CAR) / T前駆細胞 / T/NK前駆細胞 / CAR-NK細胞療法 / がん免疫療法 / 人工白血球幹細胞
  • Research Projects

    (4 results)
  • Research Products

    (6 results)
  •  Generation of Exhaustion-Resistant CAR-NK Cells for Enhanced In Vivo LongevityPrincipal Investigator

    • Principal Investigator
      重廣 司
    • Project Period (FY)
      2025 – 2027
    • Research Category
      Grant-in-Aid for Scientific Research (C)
    • Review Section
      Basic Section 54010:Hematology and medical oncology-related
    • Research Institution
      Tokyo University of Science
  •  Establishment of CAR-NK cell therapy using T/NK progenitor cellsPrincipal Investigator

    • Principal Investigator
      重廣 司
    • Project Period (FY)
      2023 – 2024
    • Research Category
      Grant-in-Aid for Early-Career Scientists
    • Review Section
      Basic Section 54010:Hematology and medical oncology-related
    • Research Institution
      Tokyo University of Science
  •  Establishment of CAR-T cell therapy utilizing precursor T cellPrincipal Investigator

    • Principal Investigator
      Shigehiro Tsukasa
    • Project Period (FY)
      2021 – 2022
    • Research Category
      Grant-in-Aid for Early-Career Scientists
    • Review Section
      Basic Section 54010:Hematology and medical oncology-related
    • Research Institution
      Tokyo University of Science
  •  Novel adoptive T cell immunotherapy using induced leukocyte stem cellPrincipal Investigator

    • Principal Investigator
      SHIGEHIRO Tsukasa
    • Project Period (FY)
      2020 – 2021
    • Research Category
      Grant-in-Aid for Research Activity Start-up
    • Review Section
      0901:Oncology and related fields
    • Research Institution
      Tokyo University of Science

All 2022 2021

All Journal Article Presentation

  • [Journal Article] FUT8-mediated Aberrant <i>N</i>-glycosylation of B7H3 Suppresses Antitumor Immunity in Triple-negative Breast Cancer2022

    • Author(s)
      Shigehiro Tsukasa
    • Journal Title

      Trends in Glycoscience and Glycotechnology

      Volume: 34 Issue: 198 Pages: E39-E40

    • DOI

      10.4052/tigg.2202.6E

    • ISSN
      0915-7352, 1883-2113
    • Year and Date
      2022-03-25
    • Language
      English
    • Data Source
      KAKENHI-PROJECT-21K16277, KAKENHI-PROJECT-20K22857
  • [Journal Article] Detection of Cancer-reactive T Cells Using α (1,3) Fucosyltransferase2021

    • Author(s)
      Shigehiro Tsukasa
    • Journal Title

      Trends in Glycoscience and Glycotechnology

      Volume: 33 Issue: 192 Pages: E45-E46

    • DOI

      10.4052/tigg.2103.6E

    • NAID

      130008002922

    • ISSN
      0915-7352, 1883-2113
    • Year and Date
      2021-03-25
    • Language
      English
    • Data Source
      KAKENHI-PROJECT-20K22857
  • [Presentation] 人工白血球幹(iLS)細胞を用いたTCF3融合遺伝子陽性B-ALL発症モデルの確立2021

    • Author(s)
      重廣司、鈴木藍彩、Gu Fangbing、平川真弓、高木正稔、犬飼岳史、伊川友活
    • Organizer
      第83回日本血液学会
    • Data Source
      KAKENHI-PROJECT-21K16277
  • [Presentation] 人工白血球幹(iLS)細胞を用いたTCF3融合遺伝子陽性B-ALL発症モデルの確立2021

    • Author(s)
      重廣司、鈴木藍彩、Gu Fangbing、平川真弓、高木正稔、犬飼岳史、伊川友活
    • Organizer
      第83回日本血液学会
    • Data Source
      KAKENHI-PROJECT-20K22857
  • [Presentation] 人工白血球幹(iLS)細胞を用いた、TCF3融合型B細胞性急性リンパ性白血病の発症機序の解明2021

    • Author(s)
      鈴木藍彩、重廣司、伊川友活
    • Organizer
      Kyoto T Cell Conference 第30回学術集会
    • Data Source
      KAKENHI-PROJECT-20K22857
  • [Presentation] 人工白血球幹(iLS)細胞を用いた、TCF3融合型B細胞性急性リンパ性白血病の発症機序の解明2021

    • Author(s)
      鈴木藍彩、重廣司、伊川友活
    • Organizer
      Kyoto T Cell Conference 第30回学術集会
    • Data Source
      KAKENHI-PROJECT-21K16277

URL: 

Are you sure that you want to link your ORCID iD to your KAKEN Researcher profile?
* This action can be performed only by the researcher himself/herself who is listed on the KAKEN Researcher’s page. Are you sure that this KAKEN Researcher’s page is your page?

この研究者とORCID iDの連携を行いますか?
※ この処理は、研究者本人だけが実行できます。

Information User Guide FAQ News Terms of Use Attribution of KAKENHI

Powered by NII kakenhi